Meeder Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Meeder Advisory Services's DGX Position: Q2 2026 in Review
Meeder Advisory Services reduced its Quest Diagnostics (DGX) stake by 6.6% in Q2 2026, selling an estimated $42.8K and leaving 3,088 shares worth $654K. The position accounts for 0.02% of the portfolio, ranked #374.
Meeder Advisory Services first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Meeder Advisory Services held 3,088 shares of Quest Diagnostics worth $654K as of Q2 2026.
- Meeder Advisory Services sold 218 Quest Diagnostics shares in Q2 2026, an estimated $42.8K.
- Quest Diagnostics made up 0.02% of Meeder Advisory Services's portfolio in Q2 2026, its #374 holding.
- Meeder Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
- 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.